Xeris Pharmaceuticals XERS 深 沪
等待开盘 11-06 09:30:00 美东时间
13.08
+2.620
+25.05%
华盛通- 最 高13.74
- 今 开12.51
- 成交量 1259.93万股
- 最 低 12.32
- 昨 收 10.46
- 总市值 23.85亿
- 52周最高 13.74
- 市盈率 静 4087.50
- 换手率 6.91%
- 52周最低 5.25
- 委 比 -51.57%
- 总股本 1.82亿
- 历史最高 27.983
- 量 比 5.23
- 振 幅 13.58%
- 历史最低 0.9701
- 每 手 1
- 风险率 1.37%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股牛股 | 业绩股逆市大涨！AppLovin飙升31%，市值近1180亿美元；Unity升14.9%，上市后首次实现季度盈利
业绩股逆市大涨！AppLovin飙升31%，市值近1180亿美元；Unity升14.9%，上市后首次实现季度盈利
今天 11:00
Xeris Biopharma Holdings Q3 2026 Earnings Call Transcript
Xeris Biopharma Holdings (NASDAQ:XERS) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below. Benzinga APIs provide real-time access to earnings call transcripts and financial data. Visit https://www.benzinga.com/a...
11-05 22:08
Xeris Biopharma Holdings FY2030 Revenue expected to be more than 1 Billion up from $750M
Xeris Biopharma Holdings (NASDAQ:XERS) FY2030 Revenue expected to be more than 1 Billion up from approximately $750 million.
11-05 20:04
Xeris Biopharma Holdings Raises FY2026 Sales Guidance from $385.000M-$390.000M to $395.000M-$405.000M vs $387.665M Est
Xeris Biopharma Holdings (NASDAQ:XERS) raises FY2026 sales outlook from $385.000 million-$390.000 million to $395.000 million-$405.000 million vs $387.665 million estimate.
11-05 20:03
Xeris Pharmaceuticals Inc收涨1.77%，成交额3419.26万美元
11月4日，Xeris Pharmaceuticals Inc（XERS）收涨1.77%，报10.35美元，成交额3419.26万美元，市值18.87亿美元。...
11-04 06:27
Xeris Pharmaceuticals Expands Board with New Independent Director
The latest update is out from Xeris Pharmaceuticals ( ($XERS) ). On November 2,...
11-02 21:36
Xeris Pharmaceuticals Inc收跌6.08%，成交额2434万美元
10月24日，Xeris Pharmaceuticals Inc（XERS）收跌6.08%，报10.2美元，成交额2434万美元，市值18.6亿美元。 行情数据...
10-24 05:30
Xeris Pharmaceuticals Inc收涨2.38%，成交额2323.13万美元
10月20-22日上海黄浦江畔，2026可持续全球领导者大会再度来袭。诺奖、图灵奖得主现场讲述科技未来与趋势，更有“解救”焦虑、内卷时代的网红教授——麦克法兰与...
10-17 05:30
Xeris Pharmaceuticals Files Patent Suits to Protect KEVEYIS
An announcement from Xeris Pharmaceuticals ( ($XERS) ) is now available. On Oct...
10-14 19:28
Xeris Biopharma Files Patent Infringement Lawsuits Related To Its KEYEVIS Product In U.S. District Court In New Jersey
On October 13, 2026, Xeris Biopharma Holdings, Inc. (the "Company"), through its wholly owned subsidiary, Xeris Pharmaceuticals, Inc., filed patent infringement lawsuits in the United States District Court for the District of New Jersey against defendants (i) Torrent Pharma Inc., Torrent Pharmaceuti...
10-14 19:12
